24 May 2013
Keywords: gsk, pre-pandemic, bird, flu, vacc, shows, cross-immunity
Article | 12 March 2007
UK drug major GlaxoSmithKline says that clinical trial data from two new studies showed significant cross-immunity for its pre-pandemic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 March 2007
23 May 2013
© 2013 thepharmaletter.com